|
1
|
Vasiliadis ES, Pneumaticos SG,
Evangelopoulos DS and Papavassiliou AG: Biologic treatment of mild
and moderate intervertebral disc degeneration. Mol Med. 20:400–409.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu H, Huang X, Liu X, Xiao S, Zhang Y,
Xiang T, Shen X, Wang G and Sheng B: miR-21 promotes human nucleus
pulposus cell proliferation through PTEN/AKT signaling. Int J Mol
Sci. 15:4007–4018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jarman JP, Arpinar VE, Baruah D, Klein AP,
Maiman DJ and Muftuler LT: Intervertebral disc height loss
demonstrates the threshold of major pathological changes during
degeneration. Eur Spine J. 24:1944–1950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samartzis D, Karppinen J, Mok F, Fong DY,
Luk KD and Cheung KM: A population-based study of juvenile disc
degeneration and its association with overweight and obesity, low
back pain and diminished functional status. J Bone Joint Surg Am.
93:662–670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bolesta MJ: Commentary on an article by
Dino Samartzis, DSc, et al.: ‘A population-based study of juvenile
disc degeneration and its association with overweight and obesity,
low back pain and diminished functional status’. J Bone Joint Surg
Am. 93:e342011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Freemont AJ: The cellular pathobiology of
the degenerate intervertebral disc and discogenic back pain.
Rheumatology (Oxford). 48:5–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Yu X, Shen J, Chan MT and Wu WK:
MicroRNA in intervertebral disc degeneration. Cell Prolif.
48:278–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao B, Yu Q, Li H, Guo X and He X:
Characterization of microRNA expression profiles in patients with
intervertebral disc degeneration. Int J Mol Med. 33:43–50. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu P, Feng B, Wang G, Ning B and Jia T:
Microarray based analysis of gene regulation by microRNA in
intervertebral disc degeneration. Mol Med Rep. 12:4925–4930. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mang Y, Li L, Ran J, Zhang S, Liu J, Li L,
Chen Y, Liu J, Gao Y and Ren G: Long noncoding RNA NEAT1 promotes
cell proliferation and invasion by regulating hnRNP A2 expression
in hepatocellular carcinoma cells. Onco Targets Ther. 10:1003–1016.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen T, Wang H, Yang P and He ZY:
Prognostic role of long noncoding RNA NEAT1 in various carcinomas:
A meta-analysis. Onco Targets Ther. 10:993–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang LQ, Yang SQ, Wang Y, Fang Q, Chen
XJ, Lu HS and Zhao LP: Long noncoding RNA MIR4697HG promotes cell
growth and metastasis in human ovarian cancer. Anal Cell Pathol
(Amst). 2017:82678632017.PubMed/NCBI
|
|
16
|
Sookoian S, Rohr C, Salatino A, Dopazo H,
Fernandez Gianotti T, Castaño GO and Pirola CJ: Genetic variation
in long noncoding RNAs and the risk of nonalcoholic fatty liver
disease. Oncotarget. 8:22917–22926. 2017.PubMed/NCBI
|
|
17
|
Song J, Park JK, Lee JJ, Choi YS, Ryu KS,
Kim JH, Kim E, Lee KJ, Jeon YH and Kim EE: Structure and
interaction of ubiquitin-associated domain of human Fas-associated
factor 1. Protein Sci. 18:2265–2276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wan ZY, Song F, Sun Z, Chen YF, Zhang WL,
Samartzis D, Ma CJ, Che L, Liu X, Ali MA, et al: Aberrantly
expressed long noncoding RNAs in human intervertebral disc
degeneration: A microarray related study. Arthritis Res Ther.
16:4652014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Urrutia J, Besa P, Campos M, Cikutovic P,
Cabezon M, Molina M and Cruz JP: The Pfirrmann classification of
lumbar intervertebral disc degeneration: An independent inter- and
intra-observer agreement assessment. Eur Spine J. 25:2728–2733.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gore M, Sadosky A, Stacey BR, Tai KS and
Leslie D: The burden of chronic low back pain: Clinical
comorbidities, treatment patterns and health care costs in usual
care settings. Spine (Phila Pa 1976). 37:E668–E677. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katz JN: Lumbar disc disorders and
low-back pain: Socioeconomic factors and consequences. J Bone Joint
Surg Am. 2 88 Suppl:S21–S24. 2006. View Article : Google Scholar
|
|
23
|
Parthan A, Evans CJ and Le K: Chronic low
back pain: Epidemiology, economic burden and patient-reported
outcomes in the USA. Expert Rev Pharmacoecon Outcomes Res.
6:359–369. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao B, Lu M, Wang D, Li H and He X:
Genome-wide identification of long noncoding RNAs in human
intervertebral disc degeneration by RNA sequencing. Biomed Res Int.
2016:36848752016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Ni H, Zhao Y, Chen K, Li M, Li C,
Zhu X and Fu Q: Potential role of lncRNAs in contributing to
pathogenesis of intervertebral disc degeneration based on
microarray data. Med Sci Monit. 21:3449–3458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mehra M, Hill K, Nicholl D and Schadrack
J: The burden of chronic low back pain with and without a
neuropathic component: A healthcare resource use and cost analysis.
J Med Econ. 15:245–252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohrt-Nissen S, Døssing KB, Rossing M,
Lajer C, Vikeså J, Nielsen FC, Friis-Hansen L and Dahl B:
Characterization of miRNA expression in human degenerative lumbar
discs. Connect Tissue Res. 54:197–203. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng J, Son DJ, Lee HL, Lee HP, Kim TH,
Joo JH, Ham YW, Kim WJ, Jung JK, Han SB and Hong JT:
(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol
suppresses ovarian cancer cell growth via inhibition of ERK and
STAT3. Mol Carcinog. 56:2003–2013. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kandala PK, Wright SE and Srivastava SK:
Blocking epidermal growth factor receptor activation by
3,3′-diindolylmethane suppresses ovarian tumor growth in vitro and
in vivo. J Pharmacol Exp Ther. 341:24–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao XP, Qian DW, Xie Z and Hui H:
Protective role of licochalcone B against ethanol-induced
hepatotoxicity through regulation of Erk signaling. Iran J Basic
Med Sci. 20:131–137. 2017.PubMed/NCBI
|
